SIO NEXT Summit

Date : Thursday, May 28, 8:00 am - Friday, May 29, 2:00 pm (EDT)

Developed in collaboration with AASLD, Society of Interventional Oncology (SIO), and the Society for Immunotherapy of Cancer (SITC), the second annual NEXT Summit: Novel Explorations in Combination Therapies will be held in Chicago on May 28-29. The program offers a dynamic, multidisciplinary environment where attendees can explore breakthrough therapeutic innovations and emerging immunotherapy strategies.

Learning Objectives 

- Critically evaluate landmark clinical trial data from 2025–2026 and translate these findings into forward-looking strategies that shape patient care. 
- Apply emerging evidence in combination and sequencing approaches to optimize IO and systemic treatment regimens across disease stages.
- Integrate clinical factors and case-based decision-making to deliver Y-90 radioembolization safely and effectively in complex hepatocellular carcinoma, including high lung shunt fractions, macrovascular invasion, large tumors, and multifocal disease.
- Evaluate emerging intratumoral agents and their role in combination immunotherapy strategies for real-world implementation of new therapeutic approaches.
- Identify where innovations in devices, imaging, and AI for interventional oncology add procedural enhancements.
- Assess the future-facing strategies, and approaches using precision medicine for patient-centered care.

View the program information online now.